Activest Wealth Management’s Akebia Therapeutics AKBA Stock Holding History

Activest Wealth Management’s Portfolio AKBA Stock Details AKBA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.84K	Hold	2,000	–	–	﹤0.01%	810
2026 Q2	$2.28K	Hold	2,000	–	–	﹤0.01%	834
2026 Q1	$2.78K	Hold	2,000	–	–	﹤0.01%	912
2025 Q4	$3.22K	Hold	2,000	–	–	﹤0.01%	826
2025 Q3	$5.46K	Hold	2,000	–	–	﹤0.01%	625
2025 Q2	$7.28K	Hold	2,000	–	–	﹤0.01%	492
2025 Q1	$3.84K	Hold	2,000	–	–	﹤0.01%	545
2024 Q4	$3.8K	Hold	2,000	–	–	﹤0.01%	391
2024 Q3	$2.64K	Hold	2,000	–	–	﹤0.01%	410
2024 Q2	$2.04K	Buy	+2,000	New	+$2.47K	﹤0.01%	399

Other funds holding AKBA

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

State of Wyoming Cheyenne, Wyoming $1.29B AUM 32.25% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Activest Wealth Management's AKBA Position: Q3 2026 in Review

Activest Wealth Management held its Akebia Therapeutics (AKBA) position steady in Q3 2026 at 2,000 shares worth $1.84K. The position accounts for ﹤0.01% of the portfolio, ranked #810.

Activest Wealth Management first reported a position in AKBA in Q2 2024 and has held it in 10 quarters since. The position peaked at $7.28K in Q2 2025. 57 funds tracked by Wall St. Rank hold AKBA as of Q3 2026.

Activest Wealth Management held 2,000 shares of Akebia Therapeutics worth $1.84K as of Q3 2026.
Activest Wealth Management left its Akebia Therapeutics share count unchanged in Q3 2026.
Akebia Therapeutics made up ﹤0.01% of Activest Wealth Management's portfolio in Q3 2026, its #810 holding.
Activest Wealth Management first reported a position in Akebia Therapeutics in Q2 2024 and has held it in 10 quarters since.
Activest Wealth Management's Akebia Therapeutics position peaked at $7.28K in Q2 2025.
57 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q3 2026.

Based on Activest Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.